Chargement en cours...
Susceptibility of Streptococcus pneumoniae to Fluoroquinolones in Canada
Ciprofloxacin, the first fluoroquinolone to be used to treat lower respiratory tract infections (LRTI), demonstrates poor potency against Streptococcus pneumoniae, and its use has been associated with the emergence of resistance. During the last decade, fluoroquinolones with enhanced in vitro activi...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Microbiology
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3147653/ https://ncbi.nlm.nih.gov/pubmed/21628545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00237-11 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|